(Q37799923)

English

Anemia in cancer

scientific article published on October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Anemia in cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

M Dicato

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

L Plawny

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

21 Suppl 7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

vii167-72

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Control of erythropoietin gene expression and its use in medicine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ284

21 January 2018

Identifiers

10.1093/ANNONC/MDQ284

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37799923&oldid=2166494626"